Shanghai Junshi Biosciences Co., Ltd. (OTCMKTS:SHJBF – Get Free Report) saw a significant decline in short interest in the month of September. As of September 30th, there was short interest totaling 200 shares, a decline of 80.0% from the September 15th total of 1,000 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is currently ∞ days.
Shanghai Junshi Biosciences Stock Performance
Shares of Shanghai Junshi Biosciences stock remained flat at C$3.35 during trading hours on Friday. Shanghai Junshi Biosciences has a 1-year low of C$2.99 and a 1-year high of C$4.23. The stock has a 50-day simple moving average of C$3.35 and a two-hundred day simple moving average of C$3.27.
About Shanghai Junshi Biosciences
Shanghai Junshi Biosciences Co, Ltd. is a China-based biopharmaceutical company focused on discovering, developing, manufacturing and commercializing innovative medicines. Its research activities cover oncology, autoimmune and inflammatory diseases, metabolic disorders, infectious diseases and other therapeutic areas, with programs based on monoclonal antibodies, small-molecule medicines and other biotechnology platforms.
The company’s best-known product is toripalimab, an anti-PD-1 monoclonal antibody marketed in China under the brand name Tuoyi.
Read More
- Five stocks we like better than Shanghai Junshi Biosciences
- 3 Stocks Chopped in Half: Why These Drops May Be Structural, Not a Dip
- Home Depot and Lowe’s Hit 52-Week Lows—But Analysts Aren’t Giving Up
- Utilities Are Bouncing Back—These 2 Giants Could Signal the Next Big Sector Rally
- Q3 Earnings Could Blow Past Consensus—Be Ready for What Comes Next
Receive News & Ratings for Shanghai Junshi Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shanghai Junshi Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
